Recombinant multi-species SYNGAP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SYNGAP1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a Ras GTPase activating protein that is a member of the N-methyl-D-aspartate receptor complex. The N-terminal domain of the protein contains a Ras-GAP domain, a pleckstrin homology domain, and a C2 domain that may be involved in binding of calcium and phospholipids. The C-terminal domain consists of a ten histidine repeat region, serine and tyrosine phosphorylation sites, and a T/SXV motif required for postsynaptic scaffold protein interaction. The encoded protein negatively regulates Ras, Rap and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking to the postsynaptic membrane to regulate synaptic plasticity and neuronal homeostasis. Allelic variants of this gene are associated with intellectual disability and autism spectrum disorder. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Nov 2016]
The Alternative Names of target: Gm1963,MRD5,Neuronal RasGAP,RASA1,RASA5,Ras/Rap GTPase-activating protein SynGAP,SYNGAP,SYNGAP1,Synaptic Ras GTPase-activating protein 1 (Synaptic Ras-GAP 1),Syngap,Syngap1
Go
to SYNGAP1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP13287-Ag-1/ GM-Tg-hg-IP13287-Ag-2 | Human SYNGAP1 protein | Human |
| GM-Tg-rg-IP13287-Ag-1/ GM-Tg-rg-IP13287-Ag-2 | Rat SYNGAP1 protein | Rat |
| GM-Tg-mg-IP13287-Ag-1/ GM-Tg-mg-IP13287-Ag-2 | Mouse SYNGAP1 protein | Mouse |
| GM-Tg-cynog-IP13287-Ag-1/ GM-Tg-cynog-IP13287-Ag-2 | Cynomolgus/Rhesus macaque SYNGAP1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP13287-Ag-1/ GM-Tg-felg-IP13287-Ag-2 | Feline SYNGAP1 protein | Feline |
| GM-Tg-cang-IP13287-Ag-1/ GM-Tg-cang-IP13287-Ag-2 | Canine SYNGAP1 protein | Canine |
| GM-Tg-bovg-IP13287-Ag-1/ GM-Tg-bovg-IP13287-Ag-2 | Bovine SYNGAP1 protein | Bovine |
| GM-Tg-equg-IP13287-Ag-1/ GM-Tg-equg-IP13287-Ag-2 | Equine SYNGAP1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP13287-Ag-1/ GM-Tg-hg-IP13287-Ag-2;
GM-Tg-rg-IP13287-Ag-1/ GM-Tg-rg-IP13287-Ag-2;
GM-Tg-mg-IP13287-Ag-1/ GM-Tg-mg-IP13287-Ag-2; GM-Tg-cynog-IP13287-Ag-1/ GM-Tg-cynog-IP13287-Ag-2; GM-Tg-felg-IP13287-Ag-1/ GM-Tg-felg-IP13287-Ag-2; GM-Tg-cang-IP13287-Ag-1/ GM-Tg-cang-IP13287-Ag-2; GM-Tg-bovg-IP13287-Ag-1/ GM-Tg-bovg-IP13287-Ag-2; GM-Tg-equg-IP13287-Ag-1/ GM-Tg-equg-IP13287-Ag-2 |
| Products Name | SYNGAP1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SYNGAP1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SYNGAP1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.